文献速递主动脉疾病

逆行性升主动脉夹层血管内治疗的长期结局

Long Term Outcomes of Endovascular Treatment for Retrograde Ascending Aortic Dissection.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2025-03-04

本研究回顾性分析了2001至2020年单中心85例逆行性升主动脉夹层患者接受胸主动脉腔内修复术(TEVAR)的长期结局。技术成功73例(86%),住院死亡1例(1%),中位随访75个月期间全因死亡率7%(6/84),1、5、10年总体生存率分别为98.8%、92.7%、88.6%。升主动脉假腔均完全血栓形成或消失,真腔直径显著增加,计算流体力学显示壁面剪切应力显著下降。

要点

  • 85例逆行性升主动脉夹层患者接受TEVAR,技术成功73例(86%),住院死亡1例(1%)。
  • 中位随访75个月,全因死亡率7%(6/84),1、5、10年总体生存率分别为98.8%、92.7%、88.6%。
  • 升主动脉真腔直径从31.8±5.2 mm增至35.4±3.5 mm(p<.001),壁面剪切应力中位数从16.4 Pa降至12.4 Pa(p=.006)。

核心结论

  • TEVAR治疗逆行性升主动脉夹层显示出令人鼓舞的短期和长期结局,提示在选定病例中可能作为开放手术的替代治疗选择。

研究设计与样本

  • 回顾性单中心研究,分析2001至2020年接受血管内治疗的逆行性升主动脉夹层病例的临床数据,共85例患者。
  • 主要终点包括主动脉相关死亡和再干预,并建立计算流体力学模型比较血管内修复后的血流动力学变化。

主要发现

  • 85例患者(平均年龄52.8±11.4岁,范围29.0-79.0岁)接受胸主动脉腔内修复术(TEVAR),技术成功73例(86%),住院死亡1例(1%)。
  • 中位随访75个月(四分位距54-101个月),全因死亡率7%(6/84,包括2例主动脉相关死亡),1、5、10年总体生存率分别为98.8%、92.7%、88.6%。
  • 随访期间15例患者共发生16例主动脉相关不良事件,包括2例近端支架诱导新发破口(SINE)、2例远端SINE和12例原发内漏进入假腔,未观察到继发性内漏。
  • 1、5、10年无主动脉相关事件率分别为77.3%、74.3%、71.5%。
  • 所有病例升主动脉假腔均完全血栓形成或消失;升主动脉真腔直径从31.8±5.2 mm(范围15.8-40.8 mm)增加至末次随访时35.4±3.5 mm(范围28.3-44.0 mm)(p<.001)。

关键数值与推荐

  • 技术成功定义为73例(86%)患者达到技术成功。
  • 主动脉相关不良事件包括近端SINE 2例、远端SINE 2例、原发内漏进入假腔12例,继发性内漏未观察到。

临床怎么用

  • 作者认为,TEVAR治疗逆行性升主动脉夹层显示出令人鼓舞的短期和长期结局,在选定病例中可能作为开放手术的替代治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The optimal treatment for retrograde ascending aortic dissection (rAAD) remains unclear. In this study, the long term clinical outcomes of endovascular treatment for rAAD were investigated retrospectively, and haemodynamic remodelling of the ascending aorta was analysed. METHODS: This retrospective, single centre study analysed clinical data of rAAD cases treated endovascularly from 2001 - 2020. Endpoints included aortic related death and re-intervention. Computational fluid dynamics (CFD) models were established to compare haemodynamic changes after endovascular repair. RESULTS: A total of 85 patients with rAAD (mean age 52.8 ± 11.4 years, range 29.0 - 79.0 years) underwent thoracic endovascular aortic repair (TEVAR). Technical success was achieved in 73 patients (86%). In hospital death occurred in one patient (1%). During the 75 month median follow up (interquartile range 54, 101 months), all cause mortality was 7% (6/84, including two aortic related deaths). Overall survival rates for one, five, and ten years were 98.8%, 92.7%, and 88.6%, respectively. Sixteen aortic related adverse events were observed in 15 patients during follow up, including two proximal stent graft induced new entries (SINEs), two distal SINEs, and 12 primary endoleaks into the false lumen. Secondary endoleak was not observed. The free from aortic related event rates for one, five, and ten years were 77.3%, 74.3%, and 71.5%, respectively. Complete thrombosis or disappearance of the false lumen in the ascending aorta was observed in all cases. The true lumen diameter of the ascending aorta increased statistically significantly from 31.8 ± 5.2 mm (range 15.8 - 40.8 mm) to 35.4 ± 3.5 mm (range 28.3 - 44.0 mm) (p < .001) at the last follow up. CFD analysis showed that the median wall shear stress in the ascending aorta statistically significantly decreased from 16.4 Pa to 12.4 Pa (p = .006). CONCLUSION: Encouraging short and long term outcomes were demonstrated using TEVAR for rAAD, suggesting that it may represent a treatment alternative to open repair in selected cases.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Peng GY, Wang M, Yao C, et al. Long Term Outcomes of Endovascular Treatment for Retrograde Ascending Aortic Dissection. Eur J Vasc Endovasc Surg. 2025. PMID: 40049318. doi:10.1016/j.ejvs.2025.02.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。